Loss of the serum response factor cofactor, cysteine-rich protein 1, attenuates neointima formation in the mouse

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 4, 2010, Pages 694-701

  Lilly, Brenda ^a,f   Clark, Kathleen A ^a   Yoshigi, Masaaki ^b   Pronovost, Stephen ^a   Wu, Meng Ling ^c   Periasamy, Muthu ^d   Chi, Mei ^d   Paul, Richard J ^e   Yet, Shaw Fang ^c   Beckerle, Mary C ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Atherosclerosis; Biology, developmental; Cell physiology; Genetically altered mice

Indexed keywords

CELL MEMBRANE PROTEIN; CONTRACTILE PROTEIN; CYSTEINE RICH PROTEIN 1; CYSTEINE RICH PROTEIN 2; LIM PROTEIN; SERUM RESPONSE FACTOR COFACTOR; UNCLASSIFIED DRUG; CSRP1 PROTEIN, MOUSE; CSRP2 PROTEIN, MOUSE; MUSCLE PROTEIN; NUCLEAR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HISTOPATHOLOGY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; STRESS; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; FEMORAL ARTERY; GENETIC TRANSFECTION; GENETICS; GENOTYPE; HYPERPLASIA; INJURY; INTIMA; METABOLISM; MOUSE MUTANT; PATHOLOGY; TIME; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FEMORAL ARTERY; GENOTYPE; HYPERPLASIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NUCLEAR PROTEINS; PHENOTYPE; TIME FACTORS; TRANSFECTION; TUNICA INTIMA; VASOCONSTRICTION;

EID: 77950893076     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.200741     Document Type: Article

References (38)

1. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75:487-517.
2. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801.
3. Miano JM, Ramanan N, Georger MA, de Mesy Bentley KL, Emerson RL, Balza RO Jr, Xiao Q, Weiler H, Ginty DD, Misra RP. Restricted inacti-vation of serum response factor to the cardiovascular system. Proc Natl Acad Sci USA. 2004;101:17132-17137.
4. Parmacek MS. Myocardin-related transcription factors: critical coactiva-tors regulating cardiovascular development and adaptation. Circ Res. 2007;100:633-644.
5. Chang DF, Belaguli NS, Iyer D, Roberts WB, Wu SP, Dong XR, Marx JG, Moore MS, Beckerle MC, Majesky MW, Schwartz RJ. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev Cell. 2003;4:107-118.
6. Wei J, Gorman TE, Liu X, Ith B, Tseng A, Chen Z, Simon DI, Layne MD, Yet SF. Increased neointima formation in cysteine-rich protein 2-deficient mice in response to vascular injury. Circ Res. 2005;97:1323-1331.
7. Pomies P, Louis HA, Beckerle MC. CRP1, a LIM domain protein implicated in muscle differentiation, interacts with alpha-actinin. J Cell Biol. 1997;139:157-168.
8. Schmeichel KL, Beckerle MC. The LIM domain is a modular protein-binding interface. Cell. 1994;79:211-219.
9. Kadrmas JL, Smith MA, Clark KA, Pronovost SM, Muster N, Yates JR III, Beckerle MC. The integrin effector PINCH regulates JNK activity and epithelial migration in concert with Ras suppressor 1. J Cell Biol. 2004;167:1019-1024.
10. Henderson JR, Macalma T, Brown D, Richardson JA, Olson EN, Beckerle MC. The LIM protein, CRP1, is a smooth muscle marker. Dev Dyn. 1999;214:229-238.
11. Jain MK, Kashiki S, Hsieh CM, Layne MD, Yet SF, Sibinga NE, Chin MT, Feinberg MW, Woo I, Maas RL, Haber E, Lee ME. Embryonic expression suggests an important role for CRP2/SmLIM in the developing cardiovascular system. Circ Res. 1998;83:980-985.
12. Lilly B, Olson EN, Beckerle MC. Identification of a CArG box-dependent enhancer within the cysteine-rich protein 1 gene that directs expression in arterial but not venous or visceral smooth muscle cells. Dev Biol. 2001; 240:531-547.
13. Louis HA, Pino JD, Schmeichel KL, Pomies P, Beckerle MC. Comparison of three members of the cysteine-rich protein family reveals functional conservation and divergent patterns of gene expression. J Biol Chem. 1997;272:27484-27491.
14. Henderson JR, Brown D, Richardson JA, Olson EN, Beckerle MC. Expression of the gene encoding the LIM protein CRP2: a developmental profile. J Histochem Cytochem. 2002;50:107-111.
15. Sambrook J, Russell DW. Molecular Cloning, A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2001.
16. Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1988.
17. Sutliff RL, Paul RJ. Mouse smooth muscle studies using gene-altered mouse models: a users' guide. In: Hoit BD, Walsh RA, eds. Cardiovascular Physiology in the Genetically Engineered Mouse. Norwell, MA: Kluwer Academic; 1998. pp. 247-257
18. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20: 335-342.
19. Raspotnig G, Fauler G, Jantscher A, Windischhofer W, Schachl K, Leis HJ. Colorimetric determination of cell numbers by Janus green staining. Anal Biochem. 1999;275:74-83.
20. Kennard S, Liu H, Lilly B. Transforming growth factor-/3 (TGF-1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. J Biol Chem. 2008;283:1324-1333.
21. Tran TC, Singleton C, Fraley TS, Greenwood JA. Cysteine-rich protein 1 (CRP1) regulates actin filament bundling. BMC Cell Biol. 2005;6:45.
22. Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard JC, Chien KR, Caroni P. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. 1997;88:393-403.
23. Omens JH, Usyk TP, Li Z, McCulloch AD. Muscle LIM protein deficiency leads to alterations in passive ventricular mechanics. Am J Physiol Heart Circ Physiol. 2002;282:H680-H687.
24. Su Z, Yao A, Zubair I, Sugishita K, Ritter M, Li F, Hunter JJ, Chien KR, Barry WH. Effects of deletion of muscle LIM protein on myocyte function. Am J Physiol Heart Circ Physiol. 2001;280:H2665-H2673.
25. Hautmann MB, Madsen CS, Owens GK. A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem. 1997;272:10948-10956.
26. Najwer I, Lilly B. Ca2+/calmodulin-dependent protein kinase IV activates cysteine-rich protein 1 through adjacent CRE and CArG elements. Am J Physiol Cell Physiol. 2005;289:C785-C793.
27. Weintraub WS. The pathophysiology and burden of restenosis. Am J Cardiol. 2007;100:3K-9K.
28. Latonen L, Jarvinen PM, Laiho M. Cytoskeleton-interacting LIM-domain protein CRP1 suppresses cell proliferation and protects from stress-induced cell death. Exp Cell Res. 2008;314:738-747.
29. Rovner AS, Murphy RA, Owens GK. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J Biol Chem. 1986;261:14740-14745.
30. Arber S, Halder G, Caroni P. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell. 1994; 79:221-231.
31. Crawford AW, Pino JD, Beckerle MC. Biochemical and molecular characterization of the chicken cysteine-rich protein, a developmentally regulated LIM-domain protein that is associated with the actin cytoskeleton. J Cell Biol. 1994;124:117-127.
32. Grubinger M, Gimona M. CRP2 is an autonomous actin-binding protein. FEBS Lett. 2004;557:88-92.
33. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132.
34. Sotiropoulos A, Gineitis D, Copeland J, Treisman R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell. 1999;98:159-169.
35. Miralles F, Posern G, Zaromytidou AI, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell. 2003; 113:329-342.
36. Mack CP, Somlyo AV, Hautmann M, Somlyo AP, Owens GK. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem. 2001;276:341-347.
37. Schwartz SM, deBlois D, O'Brien ER. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
38. Sayers RL, Sundberg-Smith LJ, Rojas M, Hayasaka H, Parsons JT, Mack CP, Taylor JM. FRNK expression promotes smooth muscle cell maturation during vascular development and after vascular injury. Arterioscler Thromb Vasc Biol. 2008;28:2115-2122.